Literature DB >> 26611634

The Hippo pathway effectors YAP and TAZ promote cell growth by modulating amino acid signaling to mTORC1.

Carsten Gram Hansen1, Yuen Lam Dora Ng1, Wai-Ling Macrina Lam1, Steven W Plouffe1, Kun-Liang Guan1.   

Abstract

YAP and TAZ are transcriptional co-activators and function as the major effectors of the Hippo tumor suppressor pathway, which controls cell growth, tissue homeostasis, and organ size. Here we show that YAP/TAZ play an essential role in amino acid-induced mTORC1 activation, particularly under nutrient-limiting conditions. Mechanistically, YAP/TAZ act via the TEAD transcription factors to induce expression of the high-affinity leucine transporter LAT1, which is a heterodimeric complex of SLC7A5 and SLC3A2. Deletion of YAP/TAZ abolishes expression of LAT1 and reduces leucine uptake. Re-expression of SLC7A5 in YAP/TAZ knockout cells restores leucine uptake and mTORC1 activation. Moreover, SLC7A5 knockout cells phenocopies YAP/TAZ knockout cells which exhibit defective mTORC1 activation in response to amino acids. We further demonstrate that YAP/TAZ act through SLC7A5 to provide cells with a competitive growth advantage. Our study provides molecular insight into the mechanism of YAP/TAZ target genes in cell growth regulation.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26611634      PMCID: PMC4670996          DOI: 10.1038/cr.2015.140

Source DB:  PubMed          Journal:  Cell Res        ISSN: 1001-0602            Impact factor:   25.617


  60 in total

1.  Regulation of mTORC1 by the Rab and Arf GTPases.

Authors:  Li Li; Eunjung Kim; Haixin Yuan; Ken Inoki; Pankuri Goraksha-Hicks; Rachel L Schiesher; Thomas P Neufeld; Kun-Liang Guan
Journal:  J Biol Chem       Date:  2010-05-10       Impact factor: 5.157

2.  TEAD/TEF transcription factors utilize the activation domain of YAP65, a Src/Yes-associated protein localized in the cytoplasm.

Authors:  A Vassilev; K J Kaneko; H Shu; Y Zhao; M L DePamphilis
Journal:  Genes Dev       Date:  2001-05-15       Impact factor: 11.361

Review 3.  The role of amino acid transporters in inherited and acquired diseases.

Authors:  Stefan Bröer; Manuel Palacín
Journal:  Biochem J       Date:  2011-06-01       Impact factor: 3.857

4.  YAP mediates crosstalk between the Hippo and PI(3)K–TOR pathways by suppressing PTEN via miR-29.

Authors:  Karen Tumaneng; Karin Schlegelmilch; Ryan C Russell; Dean Yimlamai; Harihar Basnet; Navin Mahadevan; Julien Fitamant; Nabeel Bardeesy; Fernando D Camargo; Kun-Liang Guan
Journal:  Nat Cell Biol       Date:  2012-12       Impact factor: 28.824

5.  Intracellular sensing of amino acids in Xenopus laevis oocytes stimulates p70 S6 kinase in a target of rapamycin-dependent manner.

Authors:  Graham R Christie; Eric Hajduch; Harinder S Hundal; Christopher G Proud; Peter M Taylor
Journal:  J Biol Chem       Date:  2002-01-11       Impact factor: 5.157

6.  The Hippo pathway target, YAP, promotes metastasis through its TEAD-interaction domain.

Authors:  John M Lamar; Patrick Stern; Hui Liu; Jeffrey W Schindler; Zhi-Gang Jiang; Richard O Hynes
Journal:  Proc Natl Acad Sci U S A       Date:  2012-08-13       Impact factor: 11.205

7.  Structural insights into the YAP and TEAD complex.

Authors:  Ze Li; Bin Zhao; Ping Wang; Fei Chen; Zhenghong Dong; Huirong Yang; Kun-Liang Guan; Yanhui Xu
Journal:  Genes Dev       Date:  2010-02-01       Impact factor: 11.361

8.  Yes-associated protein 1 and transcriptional coactivator with PDZ-binding motif activate the mammalian target of rapamycin complex 1 pathway by regulating amino acid transporters in hepatocellular carcinoma.

Authors:  Yun-Yong Park; Bo Hwa Sohn; Randy L Johnson; Myoung-Hee Kang; Sang Bae Kim; Jae-Jun Shim; Lingegowda S Mangala; Ji Hoon Kim; Jeong Eun Yoo; Cristian Rodriguez-Aguayo; Sunila Pradeep; Jun Eul Hwang; Hee-Jin Jang; Hyun-Sung Lee; Rajesha Rupaimoole; Gabriel Lopez-Berestein; Woojin Jeong; Inn Sun Park; Young Nyun Park; Anil K Sood; Gordon B Mills; Ju-Seog Lee
Journal:  Hepatology       Date:  2015-11-26       Impact factor: 17.425

9.  Akt maintains cell size and survival by increasing mTOR-dependent nutrient uptake.

Authors:  Aimee L Edinger; Craig B Thompson
Journal:  Mol Biol Cell       Date:  2002-07       Impact factor: 4.138

10.  Mammalian cell size is controlled by mTOR and its downstream targets S6K1 and 4EBP1/eIF4E.

Authors:  Diane C Fingar; Sofie Salama; Christina Tsou; Ed Harlow; John Blenis
Journal:  Genes Dev       Date:  2002-06-15       Impact factor: 11.361

View more
  81 in total

1.  Perspective: The Potential Role of Essential Amino Acids and the Mechanistic Target of Rapamycin Complex 1 (mTORC1) Pathway in the Pathogenesis of Child Stunting.

Authors:  Richard D Semba; Indi Trehan; Marta Gonzalez-Freire; Klaus Kraemer; Ruin Moaddel; M Isabel Ordiz; Luigi Ferrucci; Mark J Manary
Journal:  Adv Nutr       Date:  2016-09-15       Impact factor: 8.701

Review 2.  Integrin signaling: linking mechanical stimulation to skeletal muscle hypertrophy.

Authors:  Marni D Boppart; Ziad S Mahmassani
Journal:  Am J Physiol Cell Physiol       Date:  2019-07-17       Impact factor: 4.249

Review 3.  Hippo pathway effectors YAP and TAZ and their association with skeletal muscle ageing.

Authors:  Iwan Setiawan; Ardo Sanjaya; Ronny Lesmana; Paul M Yen; Hanna Goenawan
Journal:  J Physiol Biochem       Date:  2021-01-26       Impact factor: 4.158

4.  TGFβ1-induced leucine limitation uncovered by differential ribosome codon reading.

Authors:  Fabricio Loayza-Puch; Koos Rooijers; Jelle Zijlstra; Behzad Moumbeini; Esther A Zaal; Joachim F Oude Vrielink; Rui Lopes; Alejandro P Ugalde; Celia R Berkers; Reuven Agami
Journal:  EMBO Rep       Date:  2017-03-08       Impact factor: 8.807

Review 5.  Hypoxia and cellular metabolism in tumour pathophysiology.

Authors:  Scott K Parks; Yann Cormerais; Jacques Pouysségur
Journal:  J Physiol       Date:  2017-02-19       Impact factor: 5.182

6.  Phosphorylated mTOR and YAP serve as prognostic markers and therapeutic targets in gliomas.

Authors:  Mei Liu; Yong Lin; Xian-Chao Zhang; Yu-Huan Tan; Yue-Liang Yao; Juan Tan; Xia Zhang; You-Hong Cui; Xindong Liu; Yan Wang; Xiu-Wu Bian
Journal:  Lab Invest       Date:  2017-07-31       Impact factor: 5.662

Review 7.  Hippo Signaling in the Liver Regulates Organ Size, Cell Fate, and Carcinogenesis.

Authors:  Sachin H Patel; Fernando D Camargo; Dean Yimlamai
Journal:  Gastroenterology       Date:  2016-12-19       Impact factor: 22.682

8.  Mechanically tunable coaxial electrospun models of YAP/TAZ mechanoresponse and IGF-1R activation in osteosarcoma.

Authors:  Eric R Molina; Letitia K Chim; Maria C Salazar; Shail M Mehta; Brian A Menegaz; Salah-Eddine Lamhamedi-Cherradi; Tejus Satish; Sana Mohiuddin; David McCall; Ana Maria Zaske; Branko Cuglievan; Alexander J Lazar; David W Scott; Jane K Grande-Allen; Joseph A Ludwig; Antonios G Mikos
Journal:  Acta Biomater       Date:  2019-09-19       Impact factor: 8.947

9.  L-type amino acid transporter 1 promotes proliferation and invasion of human chorionic trophoblast and choriocarcinoma cells through mTORC1.

Authors:  Wenping Luo; Hongmei Zhang; Yan Zhang; Panpan Liang; Xiaojie Wang; Jing Ma; Dongmei Tan; Yi Tan; Jinlin Song; Ping Ji; Tianyu Zhao
Journal:  Am J Transl Res       Date:  2020-10-15       Impact factor: 4.060

Review 10.  Integration of Hippo-YAP Signaling with Metabolism.

Authors:  Consuelo Ibar; Kenneth D Irvine
Journal:  Dev Cell       Date:  2020-07-20       Impact factor: 12.270

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.